Annotation Detail for SUV39H1

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa00310 | Lysine degradation |
Pathway ID | Pathway Name |
---|
200191 | Regulation of retinoblastoma protein |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of SUV39H1 protein | decreases expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SUV39H1 mRNA | decreases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SUV39H1 mRNA | decreases expression | 20106945
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of SUV39H1 mRNA | increases expression | 15674844
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SUV39H1 mRNA | increases expression | 18301758
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.79 | 10378619 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.70 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.70 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.59 | 17687719 10378619 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.35 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.63 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.63 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D004487 |
Edema |
|
Mustard Gas |
8.14 | 11428647 9260866 11428631 11402378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.14 | 12083418 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.70 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.82 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.82 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.62 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 16221962 19176532 19772884 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
2.94 | 16001271 9357497 11428631 11428647 11402378 8975870 17524151 11428620 9260866 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.92 | 15890375 16377806 20007298 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.67 | 18702808 18161513 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
2.17 | 3148597 8781369 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 19348381 18481113 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
4.37 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
4.20 | 15727166 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.63 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
3.03 | 17720292 10334151 17894541 17620002 17266442 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.78 | 15451306 12880345 16961503 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |
Pathway ID |
Pathway Name |
---|
KEGG:00310 |
Lysine degradation |